3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Interventions
Inositol
6
follitropin alfa
4
Glycoprotein Hormones, alpha Subunit
3
follitropin beta
2
Metformin
2
Letrozole
2
DLBS3233
2
Clomiphene
2
Chorionic Gonadotropin
2
licogliflozin
1
elagolix
1
cetrorelix
1
Urofollitropin
1
Secretome
1
Progesterone
1
Oils
1
Menotropins
1
Leuprolide
1
Lactalbumin
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Itraconazole
1
Folic Acid
1
Diosgenin
1
Contraceptives, Oral
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Polycystic Ovary Syndrome
×
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
×
Clear all
NCT02607293
2018-06-28
ARTIST
Merck KGaA, Darmstadt, Germany
Completed
1,064 enrolled